-
Dabigatran Assay Workflows and Troubleshooting
2026-09-14
Build reproducible thrombin-generation and coagulation workflows with Dabigatran, while separating literature-backed findings from practical assay starting points. The guide also shows how to interpret Pradaxa-related activity, metabolite effects, and common PT, aPTT, and TT discrepancies.
-
β-Sitosterol–TBX20 Signaling in Colorectal Cancer
2026-09-14
This 2025 study identifies β-sitosterol as an anti-tumor component of Herba Sarcandrae and links its activity to stabilization of the tumor-suppressive transcription factor TBX20. Network pharmacology, transcriptomic analysis, cellular assays, and xenograft experiments together suggest that β-sitosterol may inhibit colorectal cancer growth, promote apoptosis, and improve sensitivity to 5-fluorouracil and oxaliplatin.
-
Anti-M1R/B6R Bispecific Antibodies for Mpox
2026-09-13
The reference study maps antibody responses to the orthopoxvirus antigens M1R and B6R and uses these data to develop antibody cocktails and bispecific formats. Its strongest translational result is protection against vaccinia virus in mice by a VH-CH1 switch region-inserting bispecific antibody, while also highlighting the need for further species, safety, and clinical validation.
-
SB 431542: Selective ALK5 Inhibitor Guide
2026-09-12
SB 431542 is an ATP-competitive ALK5 inhibitor that suppresses TGF-β receptor signaling through Smad2 phosphorylation inhibition. Its biochemical selectivity, cell-model activity, formulation data, and experimental limits make it a practical tool for TGF-β pathway and anti-tumor immunology research.
-
LY2109761 Workflow for TGF-β Studies
2026-09-11
Build cleaner TGF-β experiments with LY2109761, from acute Smad2/3 phosphorylation assays to longer-term studies of mammary epithelial plasticity, tumor invasion, radiosensitization, and fibrosis. This practical guide emphasizes dosing logic, matched controls, assay timing, and troubleshooting for reproducible pathway modulation.
-
SB 202190 (FHPI): p38 MAP Kinase Inhibitor
2026-09-11
SB 202190 is a cell-permeable p38 MAP kinase inhibitor that preferentially targets p38α and p38β through ATP-site competition. Its defined biochemical potency, pathway effects, and practical solubility profile support controlled inflammation research, cancer therapeutics research, and apoptosis assay workflows.
-
ABT-888 (Veliparib) Workflow for DNA Repair Studies
2026-09-10
ABT-888 (Veliparib) provides a controllable way to test PARP-dependent DNA repair inhibition, chemotherapy sensitization, and radiation response in cellular and xenograft models. This workflow connects established colorectal cancer and MSI applications with a recent ovarian cancer study that identifies replication stress and PPP2R2A status as practical variables for assay design.
-
Alpha-Ketoglutarate: From Flux to Immune Signal
2026-09-10
Alpha-ketoglutarate is both a tricarboxylic acid cycle intermediate and a potential tumor–macrophage signaling metabolite. This article translates cholangiocarcinoma findings into a causality-focused framework for metabolic reprogramming research, enzyme assays, and reproducible α-KGA handling.
-
L1040P Stem Cell Compound Library Guide
2026-09-09
A scenario-based guide to using the DiscoveryProbe™ Stem Cell Compound Library Plus (SKU L1040P) for reproducible viability, proliferation, differentiation, and pathway screens. It connects high-content imaging with orthogonal validation and evidence from a 280-compound stem-cell-focused screening study.
-
Fast-Dissociating Antibodies for V5 Tag Imaging
2026-09-09
Miyoshi et al. developed a semi-automated single-molecule TIRF assay that identifies highly specific, fast-dissociating monoclonal antibodies directly from hybridoma cultures. The resulting Fab probes support reversible and multiplexed imaging, and their application to inner-ear stereocilia revealed rapid espin turnover within long-lived F-actin cores.
-
LY2109761: TGF-β Dual Inhibitor Workflows
2026-09-08
LY2109761 provides a practical way to connect TβRI/II kinase blockade with phospho-Smad signaling, tumor phenotypes, radiosensitivity, and fibrosis endpoints. This workflow-focused guide covers assay setup, pathway validation, application-specific design, and troubleshooting for reproducible preclinical studies.
-
RepSox ALK5 Inhibitor for iPSC Platelet Workflows
2026-09-08
Use RepSox as a controlled ALK5 perturbation to test how TGF-β signaling influences hiPSC differentiation, megakaryocyte maturation, and platelet function. Paired with the 2026 optimized differentiation strategy, it can help separate pathway effects from gains caused by cell input, medium composition, or maturation supplements.
-
ω-Agatoxin IVA TFA: Cav2.1 Research Guide
2026-09-07
ω-Agatoxin IVA TFA provides a selective way to dissect Cav2.1-dependent calcium entry, neurotransmitter release, and nicotinic modulation. This guide connects neuronal calcium current recording with synaptic transmission research, epilepsy animal model design, troubleshooting, and neuroprotection-oriented readouts.
-
α-Synuclein Condensates and Electrostatic Partitioning
2026-09-07
The reference study shows that α-synuclein condensates possess a strongly negative electrostatic potential that controls how proteins, fluorophores, and small molecules partition into them. By combining charge-tuned fluorescent probes, zeta-potential analysis, and a differentiated SH-SY5Y model, the authors connect condensate electrostatics with both in vitro phase separation and intracellular organization.
-
CXCR4–EGFR Heteromers Rewire Cancer Signaling
2026-09-05
Comez et al. show that CXCR4 and EGFR assemble into signaling-competent oligomeric complexes whose conformation and coupling change after receptor activation. By combining NanoBRET with nanobody-based proximity ligation assays, the study connects receptor proximity to altered Gi and β-arrestin-2 signaling and detects the complexes at endogenous levels in HeLa cells.